These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3818953)

  • 1. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
    Levine MM; Herrington D; Murphy JR; Morris JG; Losonsky G; Tall B; Lindberg AA; Svenson S; Baqar S; Edwards MF
    J Clin Invest; 1987 Mar; 79(3):888-902. PubMed ID: 3818953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auxotrophic Salmonella typhi as live vaccine.
    Stocker BA
    Vaccine; 1988 Apr; 6(2):141-5. PubMed ID: 3291451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
    Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
    Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.
    Hohmann EL; Oletta CA; Killeen KP; Miller SI
    J Infect Dis; 1996 Jun; 173(6):1408-14. PubMed ID: 8648213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Salmonella typhi Ty21a vaccine for young children.
    Murphy JR; Grez L; Schlesinger L; Ferreccio C; Baqar S; Muñoz C; Wasserman SS; Losonsky G; Olson JG; Levine MM
    Infect Immun; 1991 Nov; 59(11):4291-3. PubMed ID: 1937790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
    Sztein MB; Wasserman SS; Tacket CO; Edelman R; Hone D; Lindberg AA; Levine MM
    J Infect Dis; 1994 Dec; 170(6):1508-17. PubMed ID: 7995991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate.
    Bellanti JA; Zeligs BJ; Vetro S; Pung YH; Luccioli S; Malavasic MJ; Hooke AM; Ubertini TR; Vanni R; Nencioni L
    Vaccine; 1993; 11(5):587-90. PubMed ID: 8488717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
    Levine MM; Tacket CO; Herrington D; Losonsky G; Murphy J; Ferreccio C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):459-69. PubMed ID: 3064323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
    Tacket CO; Hone DM; Losonsky GA; Guers L; Edelman R; Levine MM
    Vaccine; 1992; 10(7):443-6. PubMed ID: 1609547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.
    Sztein MB
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S15-9. PubMed ID: 17582562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
    Frey SE; Bollen W; Sizemore D; Campbell M; Curtiss R
    Clin Immunol; 2001 Oct; 101(1):32-7. PubMed ID: 11580224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
    Black R; Levine MM; Young C; Rooney J; Levine S; Clements ML; O'Donnell S; Hugues T; Germanier R
    Dev Biol Stand; 1983; 53():9-14. PubMed ID: 6307787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
    Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
    Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.
    Tacket CO; Hone DM; Curtiss R; Kelly SM; Losonsky G; Guers L; Harris AM; Edelman R; Levine MM
    Infect Immun; 1992 Feb; 60(2):536-41. PubMed ID: 1730487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
    Tacket CO; Kelly SM; Schödel F; Losonsky G; Nataro JP; Edelman R; Levine MM; Curtiss R
    Infect Immun; 1997 Aug; 65(8):3381-5. PubMed ID: 9234801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.